# IHEEZO
> **NDA216227** · New Drug Application · Sponsor: HARROW EYE · Approved 2022-09-27
## Drug
- **FDA Application Number:** NDA216227
- **Application type:** New Drug Application
- **Brand name:** IHEEZO
- **Generic name:** CHLOROPROCAINE HYDROCHLORIDE OPHTHALMIC GEL
- **Active ingredients:** CHLOROPROCAINE HYDROCHLORIDE
- **Dosage form:** GEL
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** HARROW EYE
- **Manufacturer:** Harrow Eye, LLC
- **First approval:** 2022-09-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216227)
---
*AI Analytics · CC0 1.0*